🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to determine whether a CCR2 antagonist (BMS-741...
Status
Completed
Location
Local Institution
Start Date
2009-02
Trial ID
NCT00699790
Treatments Being Tested
The study hypothesis under test is that administration of a CCR2/5 antagoni...
Status
Completed
Location
Medical Investigations, Inc.
Start Date
2012-12
Trial ID
NCT01712061
Treatments Being Tested
The purpose of this study is to test the effectiveness and safety of variou...
Status
Completed
Location
Local Institution - 0037
Start Date
2017-02-02
Trial ID
NCT02996110
Treatments Being Tested
The primary objective of this study is to evaluate the safety and efficacy ...
Status
Completed
Location
University of California San Diego
Start Date
2021-10-25
Trial ID
NCT05025787
The purpose of this study is to evaluate if the combination of nivolumab an...
Status
Completed
Location
Sidney Kimmel Comprehensive Cancer Center
Start Date
2019-12-12
Trial ID
NCT03767582
Treatments Being Tested
CLARITY 2.0 is an investigator-initiated trial that will evaluate the safet...
Status
Terminated
Location
Jawaharlal Nehru Medical College and Hospital
Start Date
2022-01-07
Trial ID
NCT05122182
Treatments Being Tested
The study hypothesis under test is that administration of the CCR2/5 antago...
Status
Terminated
Location
Retina Research Institute, LLC
Start Date
2013-11
Trial ID
NCT01994291
Treatments Being Tested